Description
Introducing Amiark-500 Injection
Amiark-500 Injection, produced by Monark Biocare Private Limited, serves as an effective antibiotic for treating serious bacterial infections. This amikacin sulphate 500mg formulation targets infections in areas like the lungs, urinary tract, skin, abdomen, and blood. Administered via injection, it provides rapid action against bacteria resistant to other antibiotics.
Key Uses and Benefits
Amiark-500 Injection combats infections caused by sensitive bacteria such as E. coli, Streptococci, and Enterococci. Healthcare providers prescribe it for conditions including pneumonia, bacteremia, bone and joint infections, and intra-abdominal infections. Its broad-spectrum efficacy makes it suitable for short-term use, typically 7 to 10 days, in hospital settings.
How It Works
The injection disrupts bacterial protein synthesis, interfering with cell membrane function and leading to bacterial death. This mechanism prevents infection spread while targeting resistant strains. Monark Biocare ensures quality production for reliable therapeutic outcomes.
Dosage and Administration
Standard dosing involves 15 mg/kg/day divided every 8-12 hours via IV or IM, adjusted for kidney function. Doctors monitor patients with blood, urine, and hearing tests during treatment. Always follow professional guidance for safe use.
Potential Side Effects and Precautions
Common issues include injection site pain, hearing impairment, kidney problems, and blood test changes. Serious risks involve rash, breathing difficulties, or severe diarrhea—seek immediate care if these occur. Avoid in pregnancy or with certain conditions like severe kidney disease; inform doctors of allergies or other medications.
